Human Papillomavirus Type 33 Polymorphisms and High-Grade Squamous Intraepithelial Lesions of the Uterine Cervix

BackgroundWe investigated the association between polymorphisms of human papillomavirus (HPV)–33 and squamous intraepithelial lesions (SILs) MethodsEndocervical specimens from 89 women infected with HPV-33, out of a total of 5347 recruited for 2 case-control and 2 cohort studies, were further analyz...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 194; no. 7; pp. 886 - 894
Main Authors Khouadri, Soraya, Villa, Luisa L., Gagnon, Simon, Koushik, Anita, Richardson, Harriet, Ferreira, Silvaneide, Tellier, Pierre, Simao, João, Matlashewski, Greg, Roger, Michel, Franco, Eduardo L., Coutlée, Francois
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.10.2006
University of Chicago Press
Subjects
Online AccessGet full text
ISSN0022-1899
1537-6613
DOI10.1086/507431

Cover

Loading…
More Information
Summary:BackgroundWe investigated the association between polymorphisms of human papillomavirus (HPV)–33 and squamous intraepithelial lesions (SILs) MethodsEndocervical specimens from 89 women infected with HPV-33, out of a total of 5347 recruited for 2 case-control and 2 cohort studies, were further analyzed by polymerase chain reaction sequencing of the long control region (LCR), E6, and E7 ResultsOf the 89 samples, 64 were normal, 7 had low-grade SILs (including 3 determined by histopathologic analysis), 15 had high-grade SILs (HSILs, including 14 determined by histopathologic analysis), and 3 had an unknown diagnosis. Non–prototype-like LCR variants were significantly associated with HSILs (age- and study site–adjusted odds ratio [OR], 9.2 [95% confidence interval {CI}, 1.8–45.9]). The C7732G variation, which results in the loss of a putative binding site for the cellular upstream stimulatory factor, was associated with HSILs (age- and site-adjusted OR, 8.0 [95% CI, 1.5–42.8]). E6 and E7 polymorphisms were not associated with HSILs. Samples collected at 6-month intervals from 14 participants contained the same variant. The HPV-33 MT 1-0-0 variant carrying the G7584A variation was detected more frequently in women from Brazil (7/20 [35%]) than in women from Canada (1/65 [1.5%]; P=.001) ConclusionIntratypic LCR variants of HPV-33 seem to vary geographically and to differ with respect to their oncogenic potential
Bibliography:ark:/67375/HXZ-BF2M3JDH-F
istex:83D723311B3B96F4B6E18C210E5F26B2B719F6A5
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-1899
1537-6613
DOI:10.1086/507431